Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT03585114

Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers

Sponsor: Columbia University

Interventions PET/CT imaging [F-18] DCFPyL

Updated 8 times since 2018 Last updated: May 6, 2022 Started: Dec 11, 2018 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Metastatic Prostate Cancer and is currently ongoing. Columbia University leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE2
Jun 2022 — Jul 2024 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Feb 2021 — Jun 2022 [monthly]

Recruiting PHASE2
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Apr 2019 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Feb 2019 — Apr 2019 [monthly]

Not Yet Recruiting PHASE2
Aug 2018 — Feb 2019 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Columbia University

Data source: Columbia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States